000 01531 a2200445 4500
005 20250514011407.0
264 0 _c20011101
008 200111s 0 0 eng d
022 _a0174-304X
024 7 _a10.1055/s-2001-17373
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHäusler, M G
245 0 0 _aPhenotypic heterogeneity and adverse effects of serine treatment in 3-phosphoglycerate dehydrogenase deficiency: report on two siblings.
_h[electronic resource]
260 _bNeuropediatrics
_cAug 2001
300 _a191-5 p.
_bdigital
500 _aPublication Type: Case Reports; Journal Article
650 0 4 _aAmino Acids
_xadverse effects
650 0 4 _aCarbohydrate Dehydrogenases
_xdeficiency
650 0 4 _aCerebrospinal Fluid
_xdrug effects
650 0 4 _aChild
650 0 4 _aChild, Preschool
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aFemale
650 0 4 _aGlycine
_xtherapeutic use
650 0 4 _aHead
_xgrowth & development
650 0 4 _aHumans
650 0 4 _aInfant
650 0 4 _aInfant, Newborn
650 0 4 _aMetabolism, Inborn Errors
_xdiagnosis
650 0 4 _aPhenotype
650 0 4 _aPhosphoglycerate Dehydrogenase
650 0 4 _aSerine
_xadministration & dosage
650 0 4 _aSpasms, Infantile
_xblood
650 0 4 _aTreatment Outcome
700 1 _aJaeken, J
700 1 _aMönch, E
700 1 _aRamaekers, V T
773 0 _tNeuropediatrics
_gvol. 32
_gno. 4
_gp. 191-5
856 4 0 _uhttps://doi.org/10.1055/s-2001-17373
_zAvailable from publisher's website
999 _c11493515
_d11493515